Long-acting injectables (LAIs) can provide numerous benefits throughout the continuum of care in certain people with schizophrenia

When used appropriately, LAIs may provide numerous benefits for patients living with schizophrenia, including increased adherence, reduced hospitalisation, and improved patient outcomes.1,2 Read the article below to learn more about LAIs and the value they hold for patients with schizophrenia.                &nb